Brian Daneshvar, Abstract Co-Author: Nothing to Disclose

Jadranka Stojanovska MD, MS, Presenter: Nothing to Disclose

Craig J. Galban PhD, Abstract Co-Author: Inventor, ImBio, LLC

Brian Dale Ross PhD, Abstract Co-Author: Co-founder, ImBio, LLC Shareholder, ImBio, LLC Advisor, ImBio, LLC

Ella A. Kazerooni MD, Abstract Co-Author: Nothing to Disclose

1. Review classification, clinical and imaging features of severity and phenotypes of Chronic Obstructive Pulmonary Disease (COPD) 2. Review COPD imaging techniques used to evaluate COPD patients in the past (chest x-ray, chest CT) and in the presence (chest CT and CT density mask) with an emphasis on technical advances (Parametric Response Map) to improve COPD outcome 3. Discuss the clinical potential of COPD phenotype imaging in evaluating these patients and to correlate clinical and imaging findings  

The spectrum of COPD phenotypes in different Global Obstructive Lung Disease (GOLD) stages with correlation between the current techniques and recent advancements such as Parametric Response Map (PRM) will be presented as clinical case series where PRM can solve the clinical conundrum. The following will be discussed: 1. Clinical significance, treatment and prognosis 2. Computed Tomography evaluation (protocols, imaging findings, and current post-processing technique) 3. Recent advances in post-processing   Current CT quantitative imaging for COPD is an important tool for providing more accurate assessment of disease severity that guides clinical management. Bringing PRM into future practice may identify a patient’s specific COPD phenotype to direct targeted and personalized therapy.  

http://abstract.rsna.org/uploads/2014/14008850/14008850_tngl.pdf

Daneshvar, B, Stojanovska, J, Galban, C, Ross, B, Kazerooni, E, Past, Present and New Era of Imaging of Chronic Obstructive Pulmonary Disease.  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14008850.html